Erythropoietin response to hypoxia in patients with diabetic autonomic neuropathy and non-diabetic chronic renal failure.
about
Remote ischaemic conditioning in the context of type 2 diabetes and neuropathy: the case for repeat application as a novel therapy for lower extremity ulcerationPredictors of cardiovascular autonomic neuropathy in patients with type 1 diabetes.The effect of altitude change on anemia treatment response in hemodialysis patientsThe anaemia of silent diabetic nephropathy-prevalence, physiopathology, and management.Effect of insulin and an erythropoietin-derived peptide (ARA290) on established neuritic dystrophy and neuronopathy in Akita (Ins2 Akita) diabetic mouse sympathetic ganglia.Association between Hemoglobin Concentration and the Progression or Development of Albuminuria in Diabetic Kidney Disease.Physiology of the Renal Interstitium.Erythropoietin and its carbamylated derivative prevent the development of experimental diabetic autonomic neuropathy in STZ-induced diabetic NOD-SCID miceLack of association between anemia and renal disease progression in Chinese patients with type 2 diabetesThe effect of altitude on dosing and response to erythropoietin in ESRDCardiovascular and renal effects of chronic exposure to high altitude.Less known pathophysiological mechanisms of anemia in patients with diabetic nephropathy.Distinct subpopulations of FOXD1 stroma-derived cells regulate renal erythropoietin.The burden of anaemia in type 2 diabetes and the role of nephropathy: a cross-sectional audit.Evaluation of the Carcinogenic Potential of Roxadustat (FG-4592), a Small Molecule Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase in CD-1 Mice and Sprague Dawley Rats.Diabetes mellitus with normal renal function is associated with anaemia.Optimized heart failure therapy and complete anemia correction on left-ventricular hypertrophy in nondiabetic and diabetic patients undergoing hemodialysis.Autonomic disturbances in diabetes: Assessment and anaesthetic implications
P2860
Q28078462-2F6B5869-404B-4694-B84F-027EFAE12310Q33165064-32CFC3E8-0EE9-4930-905B-EDD0839F5121Q35017465-A8F1C102-72A3-42D6-A98B-01C65DE63D29Q35208122-976DAD76-6345-4161-9BFD-5843AAFC58FCQ35448895-32040750-73C8-4D5D-87B0-BB3EB93B4766Q35646060-5CE63BC2-325B-41B4-A48D-36632CC60BA1Q36123584-89E83A12-2353-43AE-A1BD-4AB10053ED33Q36445059-4C4FA3A2-7BD3-4F4D-9560-80A2767C79D8Q36477666-3D600DE9-F1CA-438C-BE9A-EB23C7B905EFQ36736806-D1CE8F09-2354-4D69-91E7-77F89996B3A7Q38069142-21A0DDC9-18FA-4DE1-9020-9749A3557F94Q38504920-5CF94297-C119-43C6-8181-586678263130Q40969375-B3626A8D-C9A9-47BB-90A3-DDCB994D7F19Q44854973-B60AF5F9-1F56-41CE-9A91-5829F26FA4FDQ46258639-1E7CDB19-F5BF-46E5-B23C-22C49CF1B1FBQ50759426-DD05357E-6B9C-4764-9286-74EC980F4C67Q52934119-33F565F1-0BF7-40BE-93AE-88D305548A9BQ58805681-B19DF940-7D21-4043-A093-DA54D019A42D
P2860
Erythropoietin response to hypoxia in patients with diabetic autonomic neuropathy and non-diabetic chronic renal failure.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Erythropoietin response to hyp ...... iabetic chronic renal failure.
@en
Erythropoietin response to hyp ...... iabetic chronic renal failure.
@nl
type
label
Erythropoietin response to hyp ...... iabetic chronic renal failure.
@en
Erythropoietin response to hyp ...... iabetic chronic renal failure.
@nl
prefLabel
Erythropoietin response to hyp ...... iabetic chronic renal failure.
@en
Erythropoietin response to hyp ...... iabetic chronic renal failure.
@nl
P2093
P2860
P1433
P1476
Erythropoietin response to hyp ...... iabetic chronic renal failure.
@en
P2093
C A Osborne
D R Bosman
I C Macdougall
J T Marsden
P J Watkins
W N Gardner
P2860
P356
10.1046/J.1464-5491.2002.00634.X
P577
2002-01-01T00:00:00Z